Ginsenoside metabolite compound K promotes recovery of dextran sulfate sodium-induced colitis and inhibits inflammatory responses by suppressing NF-κB activation

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Li, Juan ^a   Zhong, Wei ^a   Wang, Weiwei ^a   Hu, Shaoping ^a   Yuan, Jiahui ^a   Zhang, Bing ^a   Hu, Tianhui ^a   Song, Gang ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CYTOKINE; GINSENOSIDE; GINSENOSIDE RB 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; DEXTRAN SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD; COLITIS; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEXTRAN SULFATE SODIUM INDUCED COLITIS; DISEASE COURSE; DOWN REGULATION; ENTERITIS; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL LINE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BERBERINE; CELL LINE; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; MACROPHAGES; MICE; NF-KAPPA B; PEROXIDASE; SIGNAL TRANSDUCTION;

EID: 84895195545     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087810     Document Type: Article

References (42)

1. Fang Y, Lihong W, Yan S, Hanwei C, Liping L, et al. (2012) BBR promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice. Am J Physiol Gastrointest Liver Physiol 302: G504-G514.
2. Sann H, Erichsen J, Hessmann M, Pahl A, Hoffmeyer A (2013) Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice. Life Sci 92: 708-718.
3. Mueller K, Blum NM, Mueller AS (2013) Examination of the Anti- Inflammatory, Antioxidant, and Xenobiotic-Inducing Potential of Broccoli Extract and Various Essential Oils during a Mild DSS-Induced Colitis in Rats. ISRN Gastroenterol 2013: 710856.
4. Yoda K, Miyazawa K, Hosoda M, Hiramatsu M, Yan F, et al. (2013) Lactobacillus GG-fermented milk prevents DSS-induced colitis and regulates intestinal epithelial homeostasis through activation of epidermal growth factor receptor. Eur J Nutr.
5. Araki A, Nara H, Rahman M, Onoda T, Li J, et al. (2013) Role of interleukin-21 isoform in dextran sulfate sodium (DSS)-induced colitis. Cytokine 62: 262-271.
6. Rieder F, Karrasch T, Ben-horin S, Schirbel A, Ehehalt R, et al. (2012) Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing. J Crohns Colitis 6: 373-385.
7. Speca S, Giusti I, Rieder F, Latella G (2012) Cellular and molecular mechanisms of intestinal fibrosis. World J Gastroenterol 18: 3635-3661.
8. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347: 417-429.
9. Blumberg RS (2009) Inflammation in the intestinal tract: pathogenesis and treatment. Dig Dis 27: 455-464.
10. Kim do Y, Park MW, Yuan HD, Lee HJ, Kim SH, et al. (2009) Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells. J Agric Food Chem 57: 10573-10578.
11. Lee ES, Choi JS, Kim MS, You HJ, Ji GE, et al. (2011) Ginsenoside metabolite compound K differentially antagonizing tumor necrosis factor-alpha-induced monocyte-endothelial trafficking. Chem Biol Interact 194: 13-22.
12. Joh EH, Lee IA, Jung IH, Kim DH (2011) Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochem Pharmacol 82: 278-286.
13. Song G, Guo S, Wang W, Hu C, Mao Y, et al. (2010) Intestinal metabolite compound K of ginseng saponin potently attenuates metastatic growth of hepatocellular carcinoma by augmenting apoptosis via a Bid-mediated mitochondrial pathway. J Agric Food Chem 58: 12753-12760.
14. Hu C, Song G, Zhang B, Liu Z, Chen R, et al. (2012) Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway. J Cell Mol Med 16: 96-106.
15. Zhang Z, Du GJ, Wang CZ, Wen XD, Calway T, et al. (2013) Compound K, a Ginsenoside Metabolite, Inhibits Colon Cancer Growth via Multiple Pathways Including p53-p21 Interactions. Int J Mol Sci 14: 2980-2995.
16. Lee IA, Hyun YJ, Kim DH (2010) Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-kappaB activation. Eur J Pharmacol 648: 162-170.
17. Jiang Q, Liu P, Wu X, Liu W, Shen X, et al. (2011) Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-kappaB signaling pathway. Mol Cell Endocrinol 331: 34-40.
18. Bae DS, Kim YH, Pan CH, Nho CW, Samdan J, et al. (2012) Protopine reduces the inflammatory activity of lipopolysaccharide-stimulated murine macrophages. BMB Rep 45: 108-113.
19. Ma BL, Yao MK, Zhong J, Ma YM, Gao CL, et al. (2012) Increased systemic exposure to rhizoma coptidis alkaloids in lipopolysaccharide-pretreated rats attributable to enhanced intestinal absorption. Drug Metab Dispos 40: 381-388.
20. Wakabayashi C, Hasegawa H, Murata J, Saiki I (1997) In vivo antimetastatic action of ginseng protopanaxadiol saponins bis based on their intestinal bacterial metabolites after oral administration. Oncol Res 9: 411-417. (Pubitemid 127825994)
21. Hasegawa H, Sung JH,Matsumiya S, Uchiyama M (1996) Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 62: 453-457. (Pubitemid 26370341)
22. Kim do Y, Yuan HD, Chung IK, Chung SH (2009) Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells. J Agric Food Chem 57: 1532-1537.
23. Lee BH, Lee SJ, Hur JH, Lee S, Sung JH, et al. (1998) In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria. Planta Med 64: 500-503. (Pubitemid 28383879)
24. Hasegawa H, Sung JH, Huh JH (1997) Ginseng intestinal bacterial metabolite IH901 as a new anti-metastatic agent. Arch Pharm Res 20: 539-544. (Pubitemid 127697216)
25. Choo MK, Sakurai H, Kim DH, Saiki I, et al. (2008) A ginseng saponinmetabolite suppresses tumor necrosis factor-alpha-promoted metastasis by suppressing nuclear factor-kappaB signaling inmurine colon cancer cells. Oncol Rep 19: 595-600. (Pubitemid 351330423)
26. Yang CS, Ko SR, Cho BG, Shin DM, Yuk JM, et al. (2008) The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock. J Cell Mol Med 12: 1739-1753.
27. Zhou X, Zhang C, Wang X, An B, Zhang P, et al. (2012) Berberine inhibits lipopolysaccharide- and polyethylene particle-induced mouse calvarial osteolysis in vivo. J Surg Res 173: e47-52.
28. Ma BL, Yao MK, Zhong J, Ma YM, Gao CL, et al. (2012) Increased systemic exposure to rhizoma coptidis alkaloids in lipopolysaccharide-pretreated rats attributable to enhanced intestinal absorption. Drug Metab Dispos 40: 381-388.
29. Lee D, Bae J, Kim YK, Gil M, Lee JY, et al. (2013) Inhibitory effects of berberine on lipopolysaccharide-induced inducible nitric oxide synthase and the high-mobility group box 1 release in macrophages. Biochem Biophys Res Commun 431: 506-511.
30. Bae DS, Kim YH, Pan CH, Nho CW, Samdan J, et al. (2012) Protopine reduces the inflammatory activity of lipopolysaccharide-stimulated murine macrophages. BMB Rep 45: 108-113.
31. Kalaiselvi P, Rajashree K, Bharathi Priya L, Padma VV (2013) Cytoprotective effect of epigallocatechin-3-gallate against deoxynivalenol- induced toxicity through anti-oxidative and anti-inflammatory mechanisms in HT-29 cells. Food Chem Toxicol 56: 110-118.
32. Bedirli A, Salman B, Pasaoglu H, Ofluoglu E, Sakrak O (2011) Effects of nuclear factor-kappaB inhibitors on colon anastomotic healing in rats. J Surg Res 171: 355-360.
33. Yan J, Xiang J, Lin Y, Ma J, Zhang J, et al. (2013) Inactivation of BAD by IKK inhibits TNFalpha-induced apoptosis independently of NF-kappaB activation. Cell 152: 304-315.
34. Jo MJ, Lee JR, Cho IJ, Kim YW, Kim SC (2013) Roots of Erigeron annuus Attenuate Acute Inflammation as Mediated with the Inhibition of NF- kappa B-Associated Nitric Oxide and Prostaglandin E2 production. Evid Based Complement Alternat Med 2013: 297427.
35. Grivennikov SI, Greten FR, Karin M (2010) Immunity, Inflammation, and Cancer. Cell 140: 883-899.
36. Aggarwal BB, Vijayalekshmi RV, Sung B (2010) Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 15: 425-430.
37. Theiss AL, Simmnons JG, Jobin C, Lund PK (2005) Tumor Necrosis Factor (TNF) a Increases Collagen Accumulation and Proliferation in Intestinal Myofibroblasts via TNF Receptor 2. J Biol Chem 280: 36099-36109. (Pubitemid 41633881)
38. Amasheh M, Fromm A, Krug SM, Amasheh S, Andres S, et al. (2010) TNF-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NF-B signaling. J Cell Sci 123: 4145-4155.
39. Schirbel A, Fiocchi C (2010) Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis 11: 266-276.
40. Abaham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361: 2066-2078.
41. Latlla G, Papi C (2012) Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol 18: 3790-3799.
42. Clark M, Colombel JF, Feagan BC, Fedorak RN, Hanauer SB, et al. (2006) American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, Gastroenterology 133: 312-339.